Autopsies performed on subjects carrying this substitution showcased beta amyloid aggregations and tau NFTs, the golden standard for diagnosing Alzheimer’s disease (Figure 1, Table 2). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.